Allurion saw its shares jump roughly 60% on Monday, Feb. 23, as the FDA signed off on the medtech’s premarket approval ...
With AI agents increasingly acting as digital concierges for shoppers, verifying bot identities, securing the APIs they rely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results